Skip to main content
Clinical Trials/NCT05811858
NCT05811858Not yet recruitingNot Applicable

Analyzing Factors Impacting Patient Involvement in Osteoarthritis Clinical Research

Power Life Sciences Inc.0 sites500 target enrollmentStarted: April 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
500
Primary Endpoint
Rate of patients who decide to enroll in an osteoarthritis clinical study.

Study Overview

Brief Summary

Clinical research participation percentages haven't always been fully representative of a given demographic.

The goal is to find out which aspects of a clinical trial may make it more difficult for patients to take part or see it through.

The data will be evaluated through different demographic lenses and identify trends that could help improve the experience of future osteoarthritis patients during clinical study.

Study Design

Study Type
Observational
Observational Model
Case Crossover
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed.
  • Participant has a diagnosis of osteoarthritis.
  • Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.

Exclusion Criteria

  • Patients with any significant history of non-compliance to medical regimens or with inability to grant a reliable informed consent.
  • Pregnant or lactating woman
  • Known medical condition that, in the investigator's opinion, would increase the risk associated with study participation or study drug(s) administration or interfere with the interpretation of safety results

Outcomes

Primary Outcomes

Rate of patients who decide to enroll in an osteoarthritis clinical study.

Time Frame: 3 months

Number of osteoarthritis patients who remain in clinical trial until completion.

Time Frame: 12 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials